The central mechanism involves both homeostatic (energy balance) and hedonic (food reward) pathways, providing comprehensive appetite regulation
The question is whether topical delivery is enough
Heres a closer look at what patients can expect, both in benefits and experience: 1
Published human evidence includes topical applications over defined periods, diabetic-ulcer wound protocols, and a registered topical acute-wound trial, while there is no FDA-approved injectable GHK-Cu label that establishes a standard dose [2], [3], [7], [8]
A central question, however, is whether AI-generated case studies can effectively simulate real-life situations
N Engl J Med 1975;292:282-4